STRAP and colorectal cancer: These findings suggest that STRAP amplification may serve as a negative prognostic marker for 5-FU-based adjuvant chemotherapy, and its copy status might be a useful parameter in the management of patients with Stage II and Stage III colorectal cancers [72].